22 JULY 2010 NEW ZEALAND GAZETTE, No. 88 2383

Classification of Medicines

Pursuant to section 106(1) of the Medicines Act 1981, I, Janice Wilson, Deputy Director-General, Population Health Directorate, Ministry of Health, acting under delegated authority, hereby declare that the medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.

This notice shall come into force on 1 May 2011.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:

(a) preparations and admixtures containing any proportion of any substance listed in the notice.

(b) salts and esters of any substance listed in the notice.

(c) preparations or extracts of biological materials listed in the notice.

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference to a medicine applies:

(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and

(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 3

Pharmacy-only Medicines

Dextromethorphan; in liquid form containing more than 0.25% or in solid dose form containing more than 15 milligrams per dose form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years

Phenylephrine; for nasal use in medicines containing more than 1%; for ophthalmic use in medicines containing 5% or less and more than 1%; for oral use in medicines containing more than 50 milligrams per recommended daily dose or in packs containing more than 250 milligrams of phenylephrine per pack; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years

Medicines for General Sale

Please note that the following medicines are now available for general sale.

Dextromethorphan; in liquid form containing 0.25% or less or in solid dose form containing 15 milligrams or less per dose form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams; except in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years

Phenylephrine; for nasal or ophthalmic use in medicines containing 1% or less; for oral use in medicines containing 50 milligrams or less per recommended daily dose and in packs containing 250 milligrams or less of phenylephrine per pack; except in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years

Dated this 13th day of July 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health.

go5553

Justice

Justices of the Peace Act 1957

Corrigendum—Justice of the Peace Resignations

In the notice with the above heading published in the New Zealand Gazette, 17 June 2010, No. 66, page 1970, please omit the name of

Afif Shah, of Auckland

which was included in error.

Dated at Wellington this 20th day of July 2010.

BELINDA CLARK, Secretary for Justice.

go5682

Authorities and Other Agencies of State Notices

Electricity Commission

Electricity Act 1992

Notice of Recommendation and Assessment Concerning the Electricity Governance (Event Causer Determination) Amendment Rules 2010

1. This notice of a recommendation and assessment concerning the Electricity Governance (Event Causer Determination) Amendment Rules 2010 is issued by the Electricity Commission (“Commission”) pursuant to section 172E(2)(c) of the Electricity Act 1992 (“Act”).

2. The Act provides that, no later than 10 working days after making a recommendation to the Minister of Energy and Resources (“Minister”) concerning the Electricity Governance Rules 2003 (“Rules”), the Commission must publicise the recommendation and the assessment completed under section 172F of the Act.

Recommended Amendments to the Rules

3. On 13 July 2010 the Commission recommended that the definition of “causer” in Part A, and Rules 11.5.1A–D of Section IV of Part C, be amended.